Skip to main content

Revance Therapeutics, Inc.

RVNCDelisted Feb 6, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001479290

Revance Therapeutics, Inc. was delisted on Feb 6, 2025; its insiders filed their last Form 4 on Feb 6, 2025; 174 institutions reported holding it in 13F filings for Q4 2024, worth $249.2M in total; Fairfax Financial was the only superinvestor holding it.

13F holders, Q2 2023

Institutional positions in Revance Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
215
−1 vs. Q1 2023
Shares held
81.8M
+5.61M (+7.4%) vs. Q1 2023
Total value
$2.07B
−$390.9M (−15.9%) vs. Q1 2023
New holders
39
86 more added
Sold out
40
60 more reduced

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RVNC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 215 institutions
Q1 2021: 149 institutionsQ2 2021: 161 institutionsQ3 2021: 159 institutionsQ4 2021: 151 institutionsQ1 2022: 156 institutionsQ2 2022: 161 institutionsQ3 2022: 182 institutionsQ4 2022: 193 institutionsQ1 2023: 217 institutionsQ2 2023: 215 institutionsQ3 2023: 187 institutionsQ4 2023: 193 institutionsQ1 2024: 188 institutionsQ2 2024: 173 institutionsQ3 2024: 201 institutionsQ4 2024: 174 institutionsQ1 2025: 2 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $2.07B
Q1 2021: $1.53BQ2 2021: $1.60BQ3 2021: $1.53BQ4 2021: $864.7MQ1 2022: $1.06BQ2 2022: $774.3MQ3 2022: $1.82BQ4 2022: $1.36BQ1 2023: $2.46BQ2 2023: $2.07BQ3 2023: $893.1MQ4 2023: $636.4MQ1 2024: $409.4MQ2 2024: $209.3MQ3 2024: $429.9MQ4 2024: $249.2MQ1 2025: $425.0KQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding RVNC and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20252$425.0K
Q4 2024174$249.2M
Q3 2024201$429.9M
Q2 2024173$209.3M
Q1 2024188$409.4M
Q4 2023193$636.4M
Q3 2023187$893.1M
Q2 2023215$2.07B
Q1 2023217$2.46B
Q4 2022193$1.36B
Q3 2022182$1.82B
Q2 2022161$774.3M
Q1 2022156$1.06B
Q4 2021151$864.7M
Q3 2021159$1.53B
Q2 2021161$1.60B
Q1 2021149$1.53B

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Revance Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding RVNC in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Goldman Sachs Group Inc1,740,902$44.1M0.01%+642,612+58.5%Added
Invesco Ltd.1,748,825$44.3M0.01%+1,527,259+689.3%Added
Jennison Associates LLC1,839,267$46.6M0.04%+205,962+12.6%Added
FMR LLC1,955,915$49.5M0.00%+110,683+6.0%Added
D. E. Shaw & Co., Inc.2,011,669$50.9M0.08%−280,242−12.2%Reduced
State Street Corp2,050,782$51.9M0.00%+103,019+5.3%Added
Franklin Resources Inc2,262,479$57.3M0.03%−12,012−0.5%Reduced
Alliancebernstein L.P.2,596,263$65.7M0.03%+617,706+31.2%Added
Thrivent Financial for Lutherans3,247,319$82.2M0.19%+1,226,338+60.7%Added
Polar Capital Holdings Plc4,167,842$105.5M0.72%00.0%Unchanged
Vanguard Group Inc4,652,776$117.8M0.00%+53,031+1.2%Added
JPMorgan Chase & Co4,693,888$118.8M0.01%−470,269−9.1%Reduced
Palo Alto Investors LP5,228,609$132.3M10.69%−41,600−0.8%Reduced
BlackRock Inc.6,526,588$165.2M0.00%+387,524+6.3%Added
Capital World Investors9,574,874$242.3M0.05%−501,227−5.0%Reduced
Jericho Capital Asset Management L.P.0$00.00%−1,438,669−100.0%Sold out
Man Group plc0$00.00%–Sold out
Assenagon Asset Management S.A.0$00.00%−194,911−100.0%Sold out
Canada Pension Plan Investment Board0$00.00%−167,568−100.0%Sold out
Lazard Asset Management LLC0$00.00%−86,155−100.0%Sold out
EAM Investors, LLC0$00.00%−79,905−100.0%Sold out
Alpha DNA Investment Management LLC0$00.00%−33,552−100.0%Sold out
BFSG, LLC0$00.00%−23,699−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−21,918−100.0%Sold out
SG Americas Securities, LLC0$00.00%−21,549−100.0%Sold out
UBS Oconnor LLC0$00.00%−20,214−100.0%Sold out
AE Wealth Management LLC0$00.00%−20,010−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−19,719−100.0%Sold out
MAI Capital Management0$00.00%−11,788−100.0%Sold out
Trexquant Investment LP0$00.00%−10,655−100.0%Sold out
Ergoteles LLC0$00.00%−10,499−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−10,009−100.0%Sold out
Exencial Wealth Advisors, LLC0$00.00%−9,045−100.0%Sold out
Kingsview Wealth Management, LLC0$00.00%−8,982−100.0%Sold out
Prudential Financial Inc0$00.00%−8,963−100.0%Sold out
Kamunting Street Capital Management, L.P.0$00.00%−7,736−100.0%Sold out
Mariner, LLC0$00.00%−7,513−100.0%Sold out
Verition Fund Management LLC0$00.00%−7,373−100.0%Sold out
Cambridge Investment Research Advisors, Inc.0$00.00%−6,981−100.0%Sold out
Flaharty Asset Management, LLC0$00.00%−6,952−100.0%Sold out
Blackhawk Capital Partners LLC.0$00.00%−6,900−100.0%Sold out
Royal Capital Wealth Management, LLC0$00.00%−6,875−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−6,840−100.0%Sold out
Systematic Financial Management LP0$00.00%−5,745−100.0%Sold out
Macroview Investment Management LLC0$00.00%−359−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−331−100.0%Sold out
Milestone Investment Advisors LLC0$00.00%−175−100.0%Sold out
Creative Planning0$00.00%−53−100.0%Sold out
Parallel Advisors, LLC0$00.00%−11−100.0%Sold out
Global Retirement Partners, LLC0$00.00%−9−100.0%Sold out
Ellevest, Inc.0$00.00%−4−100.0%Sold out
JFS Wealth Advisors, LLC0$00.00%−3−100.0%Sold out
Schubert & Co0$00.00%−1−100.0%Sold out
AdvisorNet Financial, Inc0$00.00%−1−100.0%Sold out
Disciplined Investments, LLC0$00.00%−1−100.0%Sold out
Kula Investments, LLC––––Not filed